Riparian Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Riparian Pharmaceuticals General Information

Description

Developer of pathophysiology therapeutics designed to improve endothelial function to reduce vascular complications. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases early, enabling physicians to have improved patient outcomes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 201 Dexter Avenue
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 201 Dexter Avenue
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Riparian Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jun-2026 Completed Out of Business
9. Grant 01-May-2022 Completed Generating Revenue
8. Later Stage VC (Series A2) 01-Apr-2021 Completed Generating Revenue
7. Later Stage VC (Series A1) 12-Oct-2018 Completed Generating Revenue
6. Accelerator/Incubator 05-Oct-2017 Completed Generating Revenue
5. Accelerator/Incubator 13-Oct-2016 Completed Generating Revenue
4. Accelerator/Incubator Completed Startup
3. Grant 06-Jun-2016 Completed Generating Revenue
2. Grant 01-Jan-2016 $2.83M Completed Generating Revenue
1. Grant 01-Jan-2013 $857K Completed Startup
To view Riparian Pharmaceuticals’s complete valuation and funding history, request access »

Riparian Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Riparian Pharmaceuticals’s complete cap table history, request access »

Riparian Pharmaceuticals Patents

Riparian Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025032440-A1 Klf2 inducing compounds and uses thereof Inactive 04-Aug-2023
US-20250109143-A1 Klf2 inducing deuterated compounds and uses thereof Pending 04-Aug-2023
AU-2023216716-A1 Inducers of klf2 and methods of use thereof Inactive 07-Feb-2022
EP-4476229-A1 Inducers of klf2 and methods of use thereof Pending 07-Feb-2022
EP-4476229-A4 Inducers of klf2 and methods of use thereof Pending 07-Feb-2022 C07D498/04
To view Riparian Pharmaceuticals’s complete patent history, request access »

Riparian Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Riparian Pharmaceuticals FAQs

  • When was Riparian Pharmaceuticals founded?

    Riparian Pharmaceuticals was founded in 2012.

  • Where is Riparian Pharmaceuticals headquartered?

    Riparian Pharmaceuticals is headquartered in Watertown, MA.

  • What is the size of Riparian Pharmaceuticals?

    Riparian Pharmaceuticals has 2 total employees.

  • What industry is Riparian Pharmaceuticals in?

    Riparian Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Riparian Pharmaceuticals a private or public company?

    Riparian Pharmaceuticals is a Private company.

  • What is Riparian Pharmaceuticals’s current revenue?

    The current revenue for Riparian Pharmaceuticals is .

  • How much funding has Riparian Pharmaceuticals raised over time?

    Riparian Pharmaceuticals has raised $6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process